Saratov JOURNAL of Medical and Scientific Research

Distinguishing features of the range of serum antibodies to nervous tissue antigens in Parkinson's disease

Year: 2019, volume 15 Issue: №1 Pages: 151-154
Heading: Neurology Article type: Original article
Authors: Goncharova Z.A., Kolmakova T.S., Oksenjuk O.S., Morgul E.V., Gelpey M.A., Vlasova N.D., Kalmykova Yu.A.

The goal of this study was to perform a multivariable analysis of immunobiochemical parameters which reflect the state of nervous system microstructure in Parkinson's disease (PD). Materials and Methods. The study included 54 patients of the main group with a diagnosis of PD and 6 patients of the control group. The immunoreactivity profiles of natural regulatory auto-AB in serum were determined by ELISA using the ELI-P-Complex assay. The following parameters were assessed: ABto NF-200, GFAP, S100 proteins, MBP, beta-endorphin, voltage dependent Ca2+channel, H-cholinergic receptors, glutamate, dopamine, serotonin, opiate, GABA receptors. Results. The study revealed significant abnormalities in auto-AB profiles of the examined patients. Conclusion. The findings on the difference in range of auto- AB dependent on the duration of the disease and the revealed associations with the main characteristics of the disease can be used both for early diagnosis and for predicting the course of PD in the future.

1 Goncharova ZA, Rabadanova EA, Gelpey MA. Epidemio-logical analysis of Parkinson's disease in Rostov-on-Don. Saratov Journal of Medical Scientific Research 2017; 13 (1): 135-9
2 Chernikova IV, Goncharova ZA, Hadzieva HI, et al. Clinical predictors of Parkinson's disease. Kuban Scientific Medical Herald 2015; 3 (152): 134-9
3 Gao НМ, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 2008; 29 (8): 357-65
4 Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 2009; 8 (4): 382-97
5 Ivanova SA, Alifirova VM, Semke AV, et al. Clinical and diagnostic value of medium-weight molecules in patients with mental and neurological disorders: a manual for doctors. Tomsk, 2010; 32 p.
6 Smirnova LP, Ivanova SA, Krotenko NV, et al. The State of the Antioxidant System during Therapy of Patients with Multiple Sclerosis. Biochemistry (Moscow) Supplement. Series B: Bio-medical Chemistry 2011; 5 (1): 15-8
7 Goncharova ZA, Kolmakova TS, Gelpey MA. Alpha-Synu-clein and Oxidative Stress Enzymes as Biomarkers of Parkinson's Disease. Neurochemical Journal 2017; 34 (2): 99-107
8 Klegeris A, Pelech S, Giasson Bl, et al. Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and mi-croglia. Neurobiol Aging 2008; 29 (5): 739-52
9 Bocharov EV, Kryzhanovskiy GN, Poleshhuk VV, et al. Disruption of immune and antioxidant protection in Parkinson's disease. Patogenez 2012; 10(1): 34-8
10 Matheoud D, Sugiura A, Bellemare-Pelletier A, et al. Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation. Cell 2016; 166: 314-27
11 Sulzer D, et al. T-cells of Parkinson's disease patients recognize alpha-synuclein peptides. Nature June 21, 2017: 116-21
12 Junker A, Bruck W. Auto-inflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models. Curr Opin Neurol 2012; (25): 349-57
13 Kawai T, Akira S. Innate immune recognition of viral infection. Immunol 2006; (7): 131-7
14 Doecke JD, Laws SM, Faux NG, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 2012; (69): 1318-25
15 Patejdl R, Zettl UK. Spasticity in multiple sclerosis: contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmun Rev 2017; (16): 925-36
16 JiangT, LiG, XuJ, etal. The Challenge of the Pathogen-esis of Parkinson's Disease: Is Autoimmunity the Culprit? Front Immunol, 27 September 2018 URL: 8.02047
17 Gabrielyan Nl, Lipatova VI. Experience of using the average blood molecules for the diagnosis of nephrological diseases in children. Laboratory work 1984; (3): 138-40
18 Poletaev АВ. Physiological immunology (natural auto-antibodies and problems of nanomedicine). M.: MIKLOSH, 2010; 220 p.

2019_01-1_151-154.pdf272.7 KB

No votes yet